Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients who have had a first episode of unprovoked venous thromboembolism have a high risk of recurrence after anticoagulants are discontinued. Aspirin may be effective in preventing a recurrence of venous thromboembolism. METHODS: We randomly assigned 822 patients who had completed initial anticoagulant therapy after a first episode of unprovoked venous thromboembolism to receive aspirin, at a dose of 100 mg daily, or placebo for up to 4 years. The primary outcome was a recurrence of venous thromboembolism. RESULTS: During a median follow-up period of 37.2 months, venous thromboembolism recurred in 73 of 411 patients assigned to placebo and in 57 of 411 assigned to aspirin (a rate of 6.5% per year vs. 4.8% per year; hazard ratio with aspirin, 0.74; 95% confidence interval [CI], 0.52 to 1.05; P=0.09). Aspirin reduced the rate of the two prespecified secondary composite outcomes: the rate of venous thromboembolism, myocardial infarction, stroke, or cardiovascular death was reduced by 34% (a rate of 8.0% per year with placebo vs. 5.2% per year with aspirin; hazard ratio with aspirin, 0.66; 95% CI, 0.48 to 0.92; P=0.01), and the rate of venous thromboembolism, myocardial infarction, stroke, major bleeding, or death from any cause was reduced by 33% (hazard ratio, 0.67; 95% CI, 0.49 to 0.91; P=0.01). There was no significant between-group difference in the rates of major or clinically relevant nonmajor bleeding episodes (rate of 0.6% per year with placebo vs. 1.1% per year with aspirin, P=0.22) or serious adverse events. CONCLUSIONS: In this study, aspirin, as compared with placebo, did not significantly reduce the rate of recurrence of venous thromboembolism but resulted in a significant reduction in the rate of major vascular events, with improved net clinical benefit. These results substantiate earlier evidence of a therapeutic benefit of aspirin when it is given to patients after initial anticoagulant therapy for a first episode of unprovoked venous thromboembolism. (Funded by National Health and Medical Research Council [Australia] and others; Australian New Zealand Clinical Trials Registry number, ACTRN12605000004662.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consequently, several studies have investigated the role of aspirin for the secondary prevention of VTE. 309,314,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [315]
In the citing paper
“The WARFASA 309 and ASPIRE 318 trials compared aspirin, 100 mg daily, with placebo for secondary prevention of recurrent VTE for patients with an initial unprovoked event, and the pooled results of the 2 trials showed a decrease in recurrent VTE, as well as major vascular events, without an increased risk for clinically relevant bleeding. 309,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [315]
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Systematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,401
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Systematic Reviews in Health Care: Meta‐Analysis in Context
(2001) · doi:10.1002/9780470693926 · Cited by 1,693
Heit, J. A., Mohr, D. N., Silverstein, M. D., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.761 · Cited by 1,352
(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis
Kahn, S. R., Shrier, I., Julian, J. A., Ducruet, T., Arsenault, L., Miron, M.-J., Roussin, A., Desmarais, S., Joyal, F., Kassis, J., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00004 · Cited by 854
Linkins, L.-A., Choi, P. T., & Douketis, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00007 · Cited by 764
Cited by
Items 401–500 of 600
Epperla, N., Peterson, E. L., & Foy, P. C. (2015) · BMC Hematology · doi:10.1186/s12878-015-0025-5 · Cited by 3
The secondary prevention of venous thromboembolism: Towards an individual therapeutic strategy
Elmi, G., Pizzini, A. M., & Silingardi, M. (2018) · Vascular · doi:10.1177/1708538118776896 · Cited by 3
Mengxin, Z., Sun, R., & 陈跃鑫 (2018) · Chinese Medical Sciences Journal · doi:10.24920/21805 · Cited by 3
Venous and Arterial Thrombosis Is There a Link?
Prandoni, P. (2015) · Advances in experimental medicine and biology · doi:10.1007/13780_2015_13 · Cited by 3
[European guidelines for the diagnosis and management of acute pulmonary embolism].
Cagnina, A., Michaux, S., Ancion, A., Cardos, B., Damas, F., & Lancellotti, P. (2021) · PubMed · Cited by 3
Kumbhani, D. J., Armbruster, A. L., Cheng, R. K., Chrispin, J., Fischer, U., Holbrook, A. M., Joglar, J., & Sevestre, M.-A. (2026) · JACC · doi:10.1016/j.jacc.2026.05.033 · Cited by 2
[Antithrombotic therapy after iliac vein stenting].
Zhong, W., Lou, Y., Qiu, C., Li, D., & Zhang, H. (2020) · PubMed · doi:10.3785/j.issn.1008-9292.2020.02.15 · Cited by 2
Effect of Aspirin Use on clinical Outcome among Critically Ill Patients with COVID- 19
Ali, R. M. M., Tharwat, A. I., & Labib, H. A. (2022) · Egyptian Journal of Anaesthesia · doi:10.1080/11101849.2022.2139104 · Cited by 2
Practical guide to management after an acute pulmonary embolism
Alikhan, R., Howard, L., Johnson, M., Sweeney, S., Kiely, D. G., & Pepke‐Żaba, J. (2025) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2024-003028 · Cited by 2
Enhancing Classification with Semi-Supervised Deep Learning Using Distance-Based Sample Weights
Abedinia, A., Tabakhi, S., & Seydi, V. (2025) · International Conference on Machine Learning Technologies (ICMLT) · doi:10.1109/icmlt65785.2025.11193199 · Cited by 2
Sinsakolwat, P., Trongtrakul, K., Tajarernmuang, P., Inmutto, N., Niprapan, P., Norasetthada, L., Tantiworawit, A., Rattarittamrong, E., Rattanathammethee, T., Hantrakool, S., et al. (2025) · Thrombosis Journal · doi:10.1186/s12959-025-00793-x · Cited by 2
Catheter ablation of atrial fibrillation to reduce stroke risk
Schmidt, B., Bordignon, S., Fürnkranz, A., & Chun, K. R. J. (2013) · Herz · doi:10.1007/s00059-013-3776-4 · Cited by 2
A funding model for public‐good clinical trials
Winship, I., McNeil, J. J., & Simes, R. J. (2013) · The Medical Journal of Australia · doi:10.5694/mja13.10381 · Cited by 2
In Vitro Bioequivalence of Acetylsalicylic Acid and Implications in Public Health
Bendezú, M. R., García, J. A., Chávez, H., Muñoz, A. M., Jáuregui-Nongrados, J., Mucha, M., Losno, R., Saravia, M., & Alvarado, Á. T. (2022) · Dissolution Technologies · doi:10.14227/dt290322pgc1 · Cited by 2
Komarov, A. L. (2019) · Kardiologiia · doi:10.18087/cardio.2019.2.10232 · Cited by 2
Mandlebe, B., Orundami, O. I., Lynch, L. C., Teale, G. R., Said, J. M., & Cutts, B. A. (2021) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000001053 · Cited by 2
Anticoagulants and antiaggregants in the COVID-19 era
Erlikh, A. D. (2021) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2021-11-1-58-66 · Cited by 2
Xi, Y., Mao, Y., Yang, F., Peng, X., Zhu, W. J., Song, Y., Yan, W., Liao, X., & Zhou, L. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10110461 · Cited by 2
Error-Feedback Model for Output Correction in Bilateral Control-Based Imitation Learning
Sato, H., Konosu, M., Sakaino, S., & Tsuji, T. (2025) · IEEE International Conference on Mechatronics (ICM) · doi:10.1109/icm62621.2025.10934918 · Cited by 2
LYRA, G. O. T., Katsuyama, E. S., Pincelli, M. P., de Almeida, V. P., Prado, M. L. D. L., Pereira, S. B., Tinoco, J. A., Nunes, M. A. P., & Fernandes, C. J. C. D. S. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.12.012 · Cited by 2
Trombosis venosa y arterial: semejanzas e implicaciones clínicas
Páramo, J. A. (2013) · Medicina Clínica · doi:10.1016/j.medcli.2013.07.021 · Cited by 2
Liou, K., & Lambros, J. (2014) · Heart Lung and Circulation · doi:10.1016/j.hlc.2014.06.007 · Cited by 2
Mookadam, M., Shamoun, F., Ramakrishna, H., Obeid, H., Rife, R., & Mookadam, F. (2015) · Annals of Cardiac Anaesthesia · doi:10.4103/0971-9784.166461 · Cited by 2
Managing Extended Oral Anticoagulation After Unprovoked Venous Thromboembolism
Joseph, L., & Bartholomew, J. R. (2016) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248416652236 · Cited by 2
Platelets in Deep Venous Thrombosis and Pulmonary Embolism
Pabinger, I., Riedl, J., & Panzer, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_69 · Cited by 2
Acetylsalicylsäure und venöse Thrombosen
Schrör, K. (2015) · Der Internist · doi:10.1007/s00108-014-3622-7 · Cited by 2
Venous thromboembolism: Diagnosis, treatment and the prevention of long-term complications
Barnes, G. D., Froehlich, J. B., Kanthi, Y. M., & Wakefield, T. W. (2014) · Reviews in vascular medicine · doi:10.1016/j.rvm.2014.07.005 · Cited by 2
Jiménez, D., Kopecna, D., de Miguel‐Díez, J., & Sueiro, A. (2014) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(14)70882-0 · Cited by 2
Praktyczne aspekty leczenia żylnej choroby zakrzepowo-zatorowej
Zawilska, K., & Zawilska, K. (2017) · Hematologia · doi:10.5603/hem.2016.0018 · Cited by 2
Potential risk factors for recurrent pulmonary embolism in hospitalized patients
Wang, L., Wang, W., Shu, T., Feng, P., Xiang, R., & Huang, W. C. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-36 · Cited by 2
The Year in Interventional Cardiology
Dixon, S. R., & Safian, R. D. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.040 · Cited by 2
Krasiński, Z., Urbanek, T., Undas, A., Rupa‐Matysek, J., Araszkiewicz, A., Derwich, K., Klotzka, A., Antoniewicz, A. A., Krasińska, B., Piwkowski, C., et al. (2021) · Acta Angiologica · doi:10.5603/aa.2021.0006 · Cited by 2
Comerota, A. J. (2018) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2018.03.011 · Cited by 2
Adaptive Knowledge Transfer on Evolving Domains
Wu, J., Tong, H., Ainsworth, E. A., & He, J. (2022) · IEEE International Conference on Big Data (BigData) · doi:10.1109/bigdata55660.2022.10020944 · Cited by 2
Song, J. H., Chun, K., Han, G. H., Yang, S., Yoon, S., Yuk, J., Ahn, J., Nam, S. H., Kim, J., & Kim, M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1263662 · Cited by 2
Hashimoto, H., Imai, S., Kiyomi, A., & Sugiura, M. (2022) · Thrombosis Update · doi:10.1016/j.tru.2022.100113 · Cited by 1
Optimal duration of anticoagulant therapy in patients with venous thromboembolism
Palareti, G. (2018) · Italian Journal of Medicine · doi:10.4081/item.2018.1077 · Cited by 1
Liang, J., Alavinia, M., & Kumbhare, D. A. (2018) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001046 · Cited by 1
Variational auto-encoding generative model for speech to singing voice conversion
Yousuf, A., & George, D. S. (2023) · International Conference on Electrical, Computer, Communications and Mechatronics Engineering (ICECCME) · doi:10.1109/iceccme57830.2023.10252337 · Cited by 1
Xiong, W. G., Deng, Z., Cheng, Y., Song, X., Yao, Q., Qu, J., Xu, M., Han, F., Guo, X., & Luo, Y. (2025) · BMC Medicine · doi:10.1186/s12916-025-04284-8 · Cited by 1
Chen, J., Liu, S., Shen, Y., Xiong, H., Chen, C., Xiao, B., Wang, Y., Lu, J., Yu, W., Xu, D., et al. (2025) · Thrombosis and Haemostasis · doi:10.1055/a-2706-9879 · Cited by 1
Suresh, M. G., Mohamed, S., Geetha, H. S., Sekar, A., Prabhu, S., Sargent, J., Abraham, G. M., Hatwal, J., Batta, A., & Mohan, B. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i11.110178 · Cited by 1
Managing patients with a history of arterial disease and new venous thromboembolism
Deng, E., & Passam, F. H. (2025) · Hematology · doi:10.1182/hematology.2025000683 · Cited by 1
TransFVAE: A Transformer-Based Flow Variational Autoencoder Model for Molecular Graph Generation
Ding, J., Jin, S., Meng, Y., Jin, Q., & Xu, J. (2025) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm66473.2025.11356197 · Cited by 1
Ali, M. F., Naseer, F., Hageen, A. W., Hayat, S., Rashid, Z., Momna, F. N. U., Sawaira, F., Riaz, A. A., Ahmad, H. F., Eltawansy, S., et al. (2026) · European Journal Of Haematology · doi:10.1111/ejh.70142 · Cited by 1
Conditional Inverse Design Solvers for Autonomous Manufacturing Systems with System Constraints
Na, G. S. (2025) · IEEE Annual Congress on Artificial Intelligence of Things (AIoT) · doi:10.1109/aiot66900.2025.00019 · Cited by 1
Liu, F., Chen, F., Luo, H., Qi, X., Sun, J., & Chen, Y. (2026) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2026.102505 · Cited by 1
Blickstein, D., Eliakim‐Raz, N., & Gafter‐Gvili, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011088 · Cited by 1
Na, Y. G., Fang, R., Kim, Y. H., Cho, K. J., & Kim, T. K. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.12.1865 · Cited by 1
Durée optimale du traitement anticoagulant au décours d’une embolie pulmonaire
Tromeur, C., & Couturaud, F. (2015) · La Presse Médicale · doi:10.1016/j.lpm.2015.07.005 · Cited by 1
The Optimal Duration of Anticoagulation in Patients with Unprovoked Venous Thromboembolism
Prandoni, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_108 · Cited by 1
Exploring unmet needs in venous and arterial thromboembolism with rivaroxaban
Cappato, R., & Welsh, R. C. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-06-0484 · Cited by 1
Long term use of anticoagulant therapy for patients with pulmonary embolism
Becattini, C., & Cimini, L. A. (2020) · Expert Review of Hematology · doi:10.1080/17474086.2020.1770589 · Cited by 1
Benz, A. P., & Eikelboom, J. W. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.07.023 · Cited by 1
Self-citationPlatelet recruitment to venous stent thrombi
McBane, R. D., Karnicki, K., & Wysokiński, W. E. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-0924-x · Cited by 1
Lungenembolie auf der Intensivstation
Dürschmied, D., Heinz, J., Siepe, M., & Bode, C. (2015) · Intensivmedizin up2date · doi:10.1055/s-0034-1391389 · Cited by 1
The management of venous thromboembolism: A practical tool for the front-line clinician
Bungard, T. J., & Semchuk, W. (2017) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163517691062 · Cited by 1
NEW PROSPECTS IN THE SECONDARY PREVENTION OF VENOUS THROMBOSIS
Laguta, P. S. (2016) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2016-1-5-15 · Cited by 1
Current Tendencies in the Prevention of Recurrent Venous Thromboembolism
Ilyukhin, Е. А., & Zolotukhin, I. A. (2017) · Journal of Venous Disorders · doi:10.17116/flebo201711283-90 · Cited by 1
Quel traitement anticoagulant au décours d’une embolie pulmonaire
Mao, R. L., Tromeur, C., & Couturaud, F. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.06.015 · Cited by 1
Role of Antiplatelet Drugs in Deep Vein Thrombosis
Mir, I. A. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i10.34 · Cited by 1
Anticoagulation for Proximal Deep Vein Thrombosis
Lee, A. I., & Lee, E. (2017) · Springer eBooks · doi:10.1007/978-3-319-65226-9_23 · Cited by 1
CLINICAL DISCUSSION OF A PATIENT WITH RECURRENT VENOUS THROMBOEMBOLIC COMPLICATIONS
Komarov, A. L. (2017) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2017-2-79-94 · Cited by 1
Mój pacjent leczony sulodeksydem — kiedy i dlaczego stosuję?
Gorczyca−Michta, I., & Wożakowska−Kapłon, B. (2017) · Folia Cardiologica · doi:10.5603/fc.2017.0109 · Cited by 1
Lawall, H. (2018) · Gefässchirurgie · doi:10.1007/s00772-018-0402-z · Cited by 1
Augers-Edwards, E., Harraka, R.-J., Laprise-Lachance, P., & Roy, H. (2018) · Pharmactuel · Cited by 1
Zawilska, K. (2018) · Acta Haematologica Polonica · doi:10.2478/ahp-2018-0009 · Cited by 1
Die verlängerte Sekundärprophylaxe nach venöser Thrombose
Bauersachs, R. M., & Schimmelpfennig, J. (2018) · Phlebologie · doi:10.12687/phleb2448-6-2018 · Cited by 1
Updates in venous thromboembolism management: evidence published in 2017
Bartlett, M. A., Bierle, D. M., Saadiq, R. A., Mauck, K. F., & Daniels, P. R. (2018) · Hospital Practice · doi:10.1080/21548331.2018.1486676 · Cited by 1
Chan, N., & Weitz, J. I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00059-x · Cited by 1
The Use of Antithrombotics in Critical Illness
Pfaff, A., de Laforcade, A. M., & Rozanski, E. A. (2020) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2020.07.011 · Cited by 1
Deep Vein Thrombosis and Pulmonary Embolus Thrombolysis and Endovascular Treatment
Muck, P. E. (2021) · Springer eBooks · doi:10.1007/978-1-0716-1089-3_33 · Cited by 1
Venous Thromboembolism for the Practicing Cardiologist
Pribish, A. M., Secemsky, E. A., & Schmaier, A. A. (2021) · Cardiology Clinics · doi:10.1016/j.ccl.2021.06.008 · Cited by 1
Treatment of Hemostatic Defects
Goggs, R. A. N., & Lynch, A. (2022) · Wiley eBooks · doi:10.1002/9781119500537.ch94 · Cited by 1
Role of Follow-Up Duplex Ultrasound Post-Deep Vein Thrombosis
Broering, M. J., & Muck, P. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-60626-8_67 · Cited by 1
Bauersachs, R. M., Kröger, M., Schrör, K., Hohlfeld, T., Spannagl, M., & Hart, C. (2014) · Springer eBooks · doi:10.1007/978-3-642-21496-7_5 · Cited by 1
Exploring the Target Distribution for Surrogate-Based Black-Box Attacks
Moraffah, R., Sheth, P., & Liu, H. (2022) · IEEE International Conference on Big Data (BigData) · doi:10.1109/bigdata55660.2022.10021089 · Cited by 1
Analysis of Multi-Objective Optimization of Latent Variables in Variational Autoencoders
Punnoose, A. K. (2023) · International Conference on Computing, Communication and Networking Technologies (ICCCNT) · doi:10.1109/icccnt56998.2023.10308053 · Cited by 1
Duration of anticoagulation of venous thromboembolism
Couturaud, F., Meneveau, N. F., Sevestre, M., Morange, P., & Jiménez, D. (2024) · La Presse Médicale · doi:10.1016/j.lpm.2024.104245 · Cited by 1
del Pozo, M. M., Asenjo, M. M., Franco‐Moreno, A., de Antonio, E. U., & Valle, F. G. (2024) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2024.10.004 · Cited by 1
Zhang, G., & Yan, Y. (2024) · IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS) · doi:10.1109/iros58592.2024.10802715 · Cited by 1
Disentangling Fine-Tuning from Pre-Training in Visual Captioning with Hybrid Markov Logic
Shah, M., Sarkhel, S., & Venugopal, D. (2024) · IEEE International Conference on Big Data (BigData) · doi:10.1109/bigdata62323.2024.10825003 · Cited by 1
Aspirin for prophylaxis of venous thromboembolism
Ting, C., de Carvalho, L. P., & Chan, M. Y. (2014) · ASEAN heart journal · doi:10.7603/s40602-014-0009-x · Cited by 1
Bauersachs, R. M., & Krabbe, B. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_208 · Cited by 1
The effect of Btk inhibition on platelet activation by GPVI and CLEC-2
Nicolson, P. L. R. (2019) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
Factores asociados a la recurrencia y supervivencia en el Tromboembolismo pulmonar
Sánchez, A. P., & Javier, F. (2020) · Academica-e (Universidad Pública de Navarra) · Cited by 1
Antikoagulation nach Venenthrombosen und Pulmonalembolien
Eichinger, S. (2013) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Long-Term Management of Venous Thromboembolism: Strategies for Reducing the Risk of Recurrence
Piazza, G., Hohlfelder, B., & Goldhaber, S. Z. (2015) · Springer eBooks · doi:10.1007/978-3-319-20843-5_10
Aktuelle Therapie und Sekundärprävention der Lungenembolie
Lankeit, M., & Konstantinides, S. (2013) · Der Kardiologe · doi:10.1007/s12181-013-0481-8
Interaction of blood cells with the vessel wall in thrombosis
Hansen, J., Sander, E. A., Raghavan, M. L., & Lentz, S. R. (2014) · doi:10.17077/etd.n875p8xr
Chapitre 31 – Thérapeutique de la thrombose veineuse profonde
Élias, A., & Pernod, G. (2015) · doi:10.1016/b978-2-294-74489-1.00031-0
Renaissance of Aspirin for the Primary and Secondary Prevention of Venous Thromboembolism
Burnett, A., Kelly, L. R., Horner, T., LaBaze, D., Bowman, B. N., & Mahan, C. E. (2013) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-013-0025-3
Anticoagulants : stratification du risque en pathologie vasculaire
Cohen, A. A., & Heuzey, J. Y. L. (2014) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(14)71479-x
Y a-t-il des liens entre maladie veineuse thromboembolique et risque artériel ?
Delluc, A., Lacut, K., & Mottier, D. (2014) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(14)71481-8
Aspirine et récidive de thrombose veineuse
Monsuez, J. J. (2013) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/s1261-694x(13)70459-0
Ácido acetilsalicílico en el tratamiento extendido de la enfermedad tromboembólica venosa
Riera‐Mestre, A., & Formiga, F. (2015) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2014.12.001
y, P. A., Bayés‐Genís, A., de Isla, L. P., Sanchís, J. M., & Heras, M. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.12.001
Aspirin ASPIREs to reduce vascular events after VTE
Lim, G. B. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.168
Aktuelle Therapie und Sekundärprävention der Lungenembolie
Lankeit, M., & Konstantinides, S. (2013) · Der Pneumologe · doi:10.1007/s10405-013-0744-x
Use of ASA after warfarin for unprovoked VTE.
Allan, G. M., Banh, H. L., & Ference, J. D. (2013) · Europe PMC (PubMed Central)
Metadata
- Authors
- Brighton, T. A., Eikelboom, J. W., Mann, K., Mister, R., Gallus, A., Ockelford, P., Gibbs, H., Hague, W., Xavier, D., Diaz, R., Kirby, A., & Simes, J.
- Affiliations
- Prince of Wales Hospital (AU)
- Population Health Research Institute (CA)
- The University of Sydney (AU)
- South Australia Pathology (AU)
- Auckland City Hospital (NZ)
- The Alfred Hospital (AU)
- St.John's Medical College Hospital (IN)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-11-22
- Volume
- 367
- Issue
- 21
- Pages
- 1979-1987
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2162531249
- Cited by
- 563
- References
- 24
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 39 · 2023: 24 · 2022: 25 · 2021: 33 · 2020: 37 · 2019: 30 · 2018: 35 · 2017: 49 · 2016: 51 · 2015: 56 · 2014: 60 · 2013: 69 · 2012: 8
- FWCI
- 41.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- low-dose aspirin, venous thromboembolism, recurrence prevention, unprovoked venous thromboembolism, anticoagulation discontinuation, secondary prevention, cardiovascular events, bleeding risk, major vascular events, net clinical benefit, thromboprophylaxis, stroke, myocardial infarction
- MeSH terms
- Aspirin, Double-Blind Method, Female, Follow-Up Studies, Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Risk, Incidence, Venous Thromboembolism, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.